Evidence map›Paper›PMID 31226102›Full record

ArticleMedwave2019

Congenital myasthenic syndrome due to rapsyn deficiency: A case report with a new mutation and compound heterozygosity.

Ivan O Espinoza, Carolina Reynoso, Giulliana Chávez, Andrew G Engel

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Medwave, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ivan O EspinozaUnidad de Neurología Pediátrica, Departamento de Clínicas Médicas, Universidad Peruana Cayetano Heredia, Lima, Perú. Address: Servicio de Especialidades Pediátricas del Hospital Cayetano Heredia, Avenida Honorio Delgado 262, San Martín de Porres, Lima, Perú, CP: 15102. Email: ivan.espinoza@upch.pe.
Carolina ReynosoUnidad de Neurología Pediátrica, Departamento de Clínicas Médicas, Universidad Peruana Cayetano Heredia, Lima, Perú.
Giulliana ChávezServicio de Especialidades Pediátricas, Departamento de Pediatría, Hospital Cayetano Heredia, Lima, Perú.
Andrew G EngelDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.
Universidad Peruana Cayetano Heredia · PEHospital Nacional Cayetano Heredia · PEMayo Clinic · US

Funding

ELECTRON MICROSCOPY OF MYOPATHIESR01NS006277 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE · 1985 to 2015
$7.8M
Congenital Myasthenic SyndromesR01NS109491 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE, SELCEN, DUYGU · 2019 to 2022
$1.8M
Congenital Myasthenic SyndromesR56NS006277 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE, SELCEN, DUYGU · 2017 to 2017
$539k
NINDS NIH HHS R01 NS006277NINDS NIH HHS R01 NS109491NINDS NIH HHS R56 NS006277
6 · The paper itself

Abstract

introductionThe congenital myasthenic syndromes are a heterogeneous group of genetic disorders characterized by an abnormal synaptic transmission in the neuromuscular plate. REPORT: We present a two-year-old patient, male, with hypotonia, palpebral ptosis, and proximal symmetric weakness with a neonatal onset that motivated several and prolonged hospitalizations for pneumonia and respiratory failure. From two years of age, the parents noticed that the facial and general weakness worsened in the afternoons and with repeated or prolonged physical activity. The physical examination showed palpebral ptosis, predominantly proximal weakness, and fatigability with sustained muscular effort. The electromyography showed a 27% decrement in the Compound Muscular Action Potential and the case-parents genetic study showed compound heterozygosity with the transmission of two different mutations in the rapsyn gene from both parents. The patient received pyridostigmine with great improvement, achieving optimal performance in school, sports, and daily life activities.

conclusionsWeakness and fatigability with neonatal onset, mainly affecting the muscles with brain stem innervation and the decrement greater than 10 percent in the Compound Muscular Action Potential in the electromyographic studies, should make us suspect in a congenital myasthenic syndrome. We review the literature and key clinical points to establish a timely diagnosis and effective treatment in some of these syndromes.

Indexed as

Child, PreschoolCholinesterase InhibitorsHumansMaleMuscle ProteinsMutationMyasthenic Syndromes, CongenitalPyridostigmine BromideCholinesterase InhibitorsMuscle Proteinsperipheral membrane protein 43KPyridostigmine Bromidecongenital myasthenic syndromesmissense mutationmuscle proteinsmyasthenia gravisneuromuscular junction diseases

Identifiers

PMID31226102
PMCPMC6655474
OpenAlexW2948652988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.